Literature DB >> 24793768

Expression of three essential antioxidants of Helicobacter pylori in clinical isolates.

Yan-yan Shi1, Mo Chen, Yue-xia Zhang, Jing Zhang, Shi-gang Ding.   

Abstract

OBJECTIVE: Helicobacter pylori maintains long-term persistence in the host and combats oxidative stress via many antioxidant proteins, which are expected to be relevant to bacterial-associated gastric diseases. We aimed to investigate the expression of three essential antioxidants in H. pylori strains isolated from patients with different clinical outcomes.
METHODS: Forty H. pylori strains were isolated from endoscopic biopsy specimens of gastric mucosa from 13 patients with gastric cancer, 13 with peptic ulcer, and 14 with gastritis. The expression of thioredoxin 1 (Trx1), arginase (RocF), and alkyl hydroperoxide reductase (AhpC) in H. pylori was measured by real-time PCR. Comparisons among multiple sample sets were analyzed using a one-way ANOVA test. Pearson's correlation test was used to assess relationships among multiple continuous variables.
RESULTS: Trx1 expression of H. pylori in gastric cancer and peptic ulcer tissues was higher than that in tissues with gastritis. RocF expression of H. pylori in gastric cancer tissues was higher than that in tissues exhibiting peptic ulcer and gastritis. However, we did not find any differences in AhpC expression in samples from patients with different clinical outcomes. The expression of Trx1 and RocF had a positive, linear correlation. The expression of Trx1 and AhpC had a positive correlation without a linear trend. We found no correlation between the expression of RocF and AhpC.
CONCLUSIONS: Our observations indicate that the expression of Trx1 and RocF in H. pylori might be related to gastric carcinogenesis. In H. pylori, the expression of members of the antioxidant system may be correlated and relevant to gastric cancer.

Entities:  

Keywords:  Antioxidant; Gastric cancer; Helicobacter pylori; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24793768      PMCID: PMC4076607          DOI: 10.1631/jzus.B1300171

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  24 in total

Review 1.  The diverse antioxidant systems of Helicobacter pylori.

Authors:  Ge Wang; Praveen Alamuri; Robert J Maier
Journal:  Mol Microbiol       Date:  2006-08       Impact factor: 3.501

2.  Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival.

Authors:  A P Gobert; D J McGee; M Akhtar; G L Mendz; J C Newton; Y Cheng; H L Mobley; K T Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Methionine sulfoxide reductase in Helicobacter pylori: interaction with methionine-rich proteins and stress-induced expression.

Authors:  Praveen Alamuri; Robert J Maier
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

4.  Helicobacter pylori thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses.

Authors:  David J McGee; Sateesh Kumar; Ryan J Viator; Jeffrey R Bolland; Julio Ruiz; Domenico Spadafora; Traci L Testerman; David J Kelly; Lewis K Pannell; Henry J Windle
Journal:  J Biol Chem       Date:  2005-12-14       Impact factor: 5.157

5.  Antisense RNA modulation of alkyl hydroperoxide reductase levels in Helicobacter pylori correlates with organic peroxide toxicity but not infectivity.

Authors:  Matthew A Croxen; Peter B Ernst; Paul S Hoffman
Journal:  J Bacteriol       Date:  2007-03-02       Impact factor: 3.490

6.  Oxidative-stress resistance mutants of Helicobacter pylori.

Authors:  Adriana A Olczak; Jonathan W Olson; Robert J Maier
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

7.  Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori.

Authors:  Spencer L Comtois; Mark D Gidley; David J Kelly
Journal:  Microbiology (Reading)       Date:  2003-01       Impact factor: 2.777

8.  Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta).

Authors:  Jovanny Zabaleta; David J McGee; Arnold H Zea; Claudia P Hernández; Paulo C Rodriguez; Rosa A Sierra; Pelayo Correa; Augusto C Ochoa
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

9.  Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates.

Authors:  L Chen; Q W Xie; C Nathan
Journal:  Mol Cell       Date:  1998-05       Impact factor: 17.970

10.  Genetic microheterogeneity and phenotypic variation of Helicobacter pylori arginase in clinical isolates.

Authors:  Justin G Hovey; Emily L Watson; Melanie L Langford; Ellen Hildebrandt; Sangeetha Bathala; Jeffrey R Bolland; Domenico Spadafora; George L Mendz; David J McGee
Journal:  BMC Microbiol       Date:  2007-04-04       Impact factor: 3.605

View more
  3 in total

1.  Cellular stress and redox activity proteins are involved in gastric carcinogenesis associated with Helicobacter pylori infection expressing high levels of thioredoxin-1.

Authors:  Yan-Yan Shi; Jing Zhang; Ting Zhang; Man Zhou; Ye Wang; He-Jun Zhang; Shi-Gang Ding
Journal:  J Zhejiang Univ Sci B       Date:  2018 Oct.       Impact factor: 3.066

2.  Arginase-1 and Treg Profile Appear to Modulate Inflammatory Process in Patients with Chronic Gastritis: IL-33 May Be the Alarm Cytokine in H. pylori-Positive Patients.

Authors:  Emerson Abdulmassih Wood da Silva; Natalia Maria Jacom Wood da Silva; Rafael Rocha Rodrigues; Sheila Jorge Adad; Sanívia Aparecida de Lima Pereira; Betânia Maria Ribeiro; Mônica Sawan Mendonça; Fernanda R Helmo; Virmondes Rodrigues; Denise Bertulucci Rocha Rodrigues
Journal:  Mediators Inflamm       Date:  2019-06-20       Impact factor: 4.711

3.  Helicobacter pylori Thioredoxin1 May Play a Highly Pathogenic Role via the IL6/STAT3 Pathway.

Authors:  Yanlei Guo; Shigang Ding
Journal:  Gastroenterol Res Pract       Date:  2022-08-01       Impact factor: 1.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.